Enhanced replication of M-tropic HIV-1 strains in Herpesvirus saimiri immortalised T-cells which express CCR5

Journal of Virological Methods

Volumn 79, Issue 1, 1999, Pages 51-63

  Vella, C ^a   Zheng, N N ^a   Vella, G ^a   Atkins, C ^a   Bristow, R G W ^b   Fickenscher, H ^c   Daniels, R S ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Murex Biotech Ltd   (United Kingdom)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Enhanced replication; HVS T cells; M tropic HIV 1

Indexed keywords

ARTICLE; CELL IMMORTALIZATION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTIVITY; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HERPESVIRUS 2, SAIMIRIINE; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; RANTES; RECEPTORS, CCR5; T-LYMPHOCYTE SUBSETS; TROPISM; VIRUS REPLICATION;

EID: 0032960884     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00006-3     Document Type: Article

References (49)

1. Akari H., Mori K., Terao K., Otani I., Fukasawa M., Mukai R., Yoshikawa Y. In vitro immortalisation of Old World monkey T lymphocytes with Herpesvirus saimiri: Its susceptibility to infection with simian immunodeficiency viruses. Virology. 218:1996;382-388.
2. Albert J., Naucler A., Bottiger B., Broliden P.-A., Albino P., Ouattara S.A., Bjorkegren C., Valentin A., Biberfeld G., Fenyö E.M. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS. 4:1990;291-295.
3. + T-lymphocyte activity. J. Virol. 72:1998;1627-1631.
4. Biesinger B., Müller-Fleckenstein I., Simmer B., Lang G., Wittman S., Platzer E., Desrosiers R., Fleckenstein B. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc. Natl. Acad. Sci. USA. 89:1992;316-319.
5. Bleul C.C., Wu L., Hoxie J.A., Springer T.A., Mackay C.R. The HIV coreceptors CXCR-4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA. 94:1997;1925-1930.
6. Capobianchi M.R., Abbate I., Antonelli G., Turriziani O., Dolei A., Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages. AIDS Res. Hum. Retroviruses. 14:1998;233-240.
7. Cheng-Mayer C., Seto D., Levy J.A. Altered host range of HIV-1 after passage through various human cell types. Virology. 181:1991;288-294.
8. Chesebro B., Nishio J., Perryman S., Cann A., O'Brien W., Chen I.S.Y, Wehrly K. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-Leukemia cells, and macrophages. J. Virol. 65:1991;5782-5789.
9. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:1997;621-628.
10. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
11. De Jong J-J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., De Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992a;757-765.
12. De Jong J-J., De Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype; analysis by single amino acid substitution. J. Virol. 66:1992b;6777-6780.
13. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
14. Dolei A., Biolchini A., Serra C., Curreli S., Gomes E., Dianzani F. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS. 12:1998;183-190.
15. + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
16. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
17. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a 7-transmembrane, G-protein-coupled receptor. Science. 272:1996;872-877.
18. Fenyö E.M., Mordfeldt-Manson L., Chiodi F., Lind B., von Gegerfelt A., Albert J., Olausson E., Asjo B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:1988;4414-4419.
19. Fouchier R.A.M., Groenink M., Kootstra N.A., Tersmette M., Huisman H.G., Miedema F., Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:1992;3183-3187.
20. + T cell decline in vivo. Virology. 219:1996;87-95.
21. Fredriksson R., Stalhanske P., von Gegerfelt A., Lind B., Aman P., Rassart E., Fenyö E.M. Biological characterization of infectious molecular clones derived from a human immunodeficiency virus type-1 isolate with rapid/high replicative capacity. Virology. 181:1991;55-61.
22. +lymphocytes are not related to ß-chemokine production. AIDS Res. Hum. Retroviruses. 16:1998;1407-1411.
23. + T cells. Clin. Exp. Immunol. 107:1997;300-305.
24. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
25. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N.R., Phair J., Ho D.D., Koup R.A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1996;1240-1243.
26. + T cell suppression of syncytia-inducing strains of HIV-1. Proc. Natl. Acad. Sci. USA. 94:1997;9842-9847.
27. Landau N.R., Littman D.R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66:1992;5110-5113.
28. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
29. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt-Månson L., Asjö B., Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:1989;901-910.
30. Michael N.L., Chang G., Louie L.G., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W. The role of viral phenotype and CCR5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3:1997;338-340.
31. Mittrücker H.W., Müller-Fleckenstein I., Fleckenstein B., Fleischer B. CD2-mediated autocrine growth of Herpesvirus saimiri-transformed human T-lymphocytes. J. Exp. Med. 176:1992;909-914.
32. Nakajima-Iijima S., Hamada H., Reddy P., Kakunaga T. Molecular structure of the human β-actin gene: interspecies homology of sequences in the introns. Proc. Nat.l Acad. Sci. USA. 82:1985;6133-6137.
33. Nick S., Fickenscher H., Biesinger B., Born G., Jahn G., Fleckenstein B. Herpes saimiri transformed human T-cell lines: a permissive system for human immunodeficiency viruses. Virology. 194:1993;875-877.
34. Penny M.A., Thomas S.J., Douglas N.W., Ranjbar S., Holmes H., Daniels R.S. Env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization network for HIV isolation and characterization. AIDS Res. Hum. Retroviruses. 12:1996;741-747.
35. + T-cell clones from peripheral blood lymphocytes of AIDS patients. J. Immunol. Methods. 206:1997;21-23.
36. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 HIV-1-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J. Virol. 72:1998;876-881.
37. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning, A Laboratory Manual. 2nd edition:1989;7.12-7.15 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
38. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
39. + memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc. Natl. Acad. Sci. USA. 87:1990;6058-6062.
40. Schuitemaker H., Kootstra N.A., de Goede R.E.Y., de Wolf F., Miedema F., Tersmette M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:1991;356-363.
41. Schuitemaker H., Koot M., Kootstra N.A., Dercksen M.W., de Goede R.E.Y., van Steenwijk R.P., Lange J.M.A., Eeftink Schattenkerk J.K., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1992;1354-1360.
42. Simon F., Matherson S., Tamalet C., Loussert-Ajaka I., Bartczak S., Pepin J.M., Dhiver C., Gamba E., Elbim C., Gastaut J.A., Saimot A.G., Brun-Vezinet F. Cellular and plasma viral load in patients infected with HIV-2. AIDS. 7:1993;1411-1417.
43. Spira A., Ho D.D. Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J. Virol. 69:1995;422-429.
44. + T lymphocytes of HIV-infected subjects. J. Acquired Immune Deficiency Syndrome. 6:1993;749-757.
45. Vella C., Fickenscher H., Atkins C., Penny M., Daniels R. Herpesvirus saimiri-immortalized human T-cells support long term, high titred replication of human immunodefdiciency virus types 1 and 2. J. Gen. Virol. 78:1997;1405-1409.
46. Williams L., Cloyd M. Polymorphic human gene determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology. 184:1991;723-728.
47. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature. 384:1996;179-183.
48. Wu L., Paxton W.A., Kassam N., Ruffing N., Rottman J.B., Sullivan N., Choe H., Sodroski J., Newman W., Koup R.A., Mackay C.R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1997;1681-1691.
49. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1993;1179-1181.